Finance

Lists
Q3 2026 earnings • released • EPS beat +43,20% • Revenue beat +2,23%
See results
XPER:NYSE
Xperi Inc
USD 5,82
+1,93%
(+0,11) 1D
6 Nov., 10:49:15 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XPER...
Open
USD 5,72
High
USD 5,86
Low
USD 5,62
Mkt. cap
283,85 m
Avg. vol.
446,41 k
Volume
68,80 k
52-wk high
USD 8,75
52-wk low
USD 4,91
EPS
-USD 0,70
Beta
0,90
Shares outstanding
48,77 m
No. of employees
1 k
Open
USD 5,72
High
USD 5,86
Low
USD 5,62
Mkt. cap
283,85 m
Avg. vol.
446,41 k
Volume
68,80 k
52-wk high
USD 8,75
52-wk low
USD 4,91
EPS
-USD 0,70
Beta
0,90
Shares outstanding
48,77 m
No. of employees
1 k
News stories
From web sources and news partners
About Xperi Inc
CEO-
Employees1,38 k
Founded2019
HeadquartersSan Jose, Kalifornië, Verenigde State van Amerika
SectorInformation Technology
Industry-
Websitexperi.com
Analyst ratings
Based on 2 analysts giving stock ratings to XPER in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for XPER in the last 3 months.
Highest
Current USD 5,82
USD 13,00 (+123,37%)
Average
USD 12,50 (+114,78%)
Lowest
USD 12,00 (+106,19%)
Analyst
Recommendation
Action
Price target
Projected
Date
Hamed Khorsand
BWS Financial
Buy
Maintained
USD 12,00
+106,2%
08/07/2026
Matthew Galinko
Maxim Group
Buy
Maintained
USD 13,00
+123,4%
08/07/2026
Steve Frankel
Rosenblatt Securities
Buy
Maintained
USD 10,00
+71,8%
08/06/2026
Jason Kreyer
Craig-Hallum
Buy
Maintained
USD 10,00
+71,8%
08/06/2026
Unknown Analyst
Rosenblatt Securities
Buy
Maintained
USD 10,00
+71,8%
05/06/2026
Last report
05 Nov. 2026
Fiscal period
Q3 2026
USD 0,24 / USD 0,17
+43,20%beat
Revenue / Est. (USD)
113,95 m / 111,47 m
+2,23%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
116,51 m
114,21 m
114,49 m
113,95 m
Cost of goods sold
32,12 m
30,88 m
36,07 m
35,50 m
Cost of revenue
32,12 m
30,88 m
36,07 m
35,50 m
Research and development expenses
27,85 m
27,08 m
21,81 m
23,49 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
45,86 m
41,79 m
41,46 m
41,65 m
Operating expense
85,30 m
81,18 m
75,31 m
76,69 m
Total operating expenses
117,42 m
112,06 m
111,38 m
112,19 m
Operating income
-908,00 k
2,15 m
3,11 m
1,76 m
Other non operating income
-
-
-
-
EBT including unusual items
-14,29 m
2,29 m
3,33 m
2,14 m
EBT excluding unusual items
-405,00 k
2,29 m
3,52 m
2,14 m
Income tax expense
2,79 m
10,12 m
4,83 m
7,38 m
Effective tax rate
-19,53%
441,45%
145,10%
344,68%
Other operating expenses
-
-
-
-
Net income
-17,08 m
-7,83 m
-1,50 m
-5,24 m
Net profit margin
-14,66%
-6,85%
-1,31%
-4,60%
Earnings per share
0,24
0,23
0,28
0,24
Interest and investment income
1,23 m
819,00 k
1,10 m
1,07 m
Interest expense
-727,00 k
-678,00 k
-684,00 k
-694,00 k
Net interest expenses
503,00 k
141,00 k
413,00 k
379,00 k
Depreciation and amortization charges
3,60 m
4,26 m
3,95 m
3,68 m
EBITDA
3,44 m
11,62 m
12,59 m
18,72 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme